In this podcast, Nicholas Villalobos, MD, interviews Hatem Soliman Aboumarie, MD, from Harefield Hospital, the Royal Brompton and Harefield Hospitals, London. They discuss cardiovascular ICU principles and updates in bedside cardiac ultrasound from the 2025 Cardiac Ultrasound in Cardiovascular Emergency and Critical Care consensus statement by the European Association of Cardiovascular Imaging, the Acute CardioVascular Care Association of the European Society of Cardiology, and the European Association of Cardiothoracic Anaesthesia and Intensive Care. This discussion involves updates in spectral Doppler, strain imaging, and applications of artificial intelligence.

Presented by the Ultrasound and Chest Imaging Section of the CHEST Thoracic Oncology and Chest Procedures Network.

In this podcast episode, in honor of Women's History Month, the Women in Chest Medicine Interest Group highlights the leadership journey, values, and insights of CHEST President-Elect Lisa K. Moores, MD, FCCP, in a conversation with host Margaret Pisani, MD, MPH, FCCP. Through a reflective and engaging discussion, Dr. Moores shares how her experiences—from competitive athletics to a distinguished military and medical career—shaped her leadership style grounded in discipline, service, inclusivity, and kindness. The episode explores the critical role of mentorship and sponsorship, addresses challenges such as work-life integration and imposter syndrome, and offers practical, actionable advice for women at all career stages in medicine.

Farrukh Abbas, MD, FCCP, and Megan Conroy, MD, MAEd, FCCP, discuss the role of the care team in COPD diagnosis, recent changes in classifications and updates to the Global Initiative for Chronic Obstructive Lung Disease guidelines, how triple-inhaler therapies and biologics can be used to treat patients with COPD, and more.

Since the time of this recording, the US Food and Drug Administration has approved dupilumab as an add-on maintenance treatment for adult patients with inadequately controlled COPD with type 2 inflammation.

This podcast is a part of CHEST's Bridging Specialties®: Timely Diagnosis and Treatment for COPD program. Access more resources at chestnet.org/timely-diagnosis-COPD.

Primary care providers can play a pivotal role in a patient’s COPD diagnosis by looking out for signs and symptoms and referring patients to pulmonologists when appropriate. In this podcast, Megan Conroy, MD, MEd, FCCP, and Nathan Falk, MD, MBA, CPE, CAQSM, FAAFP, provide pulmonary and primary care perspectives on diagnostic strategies for COPD.

This podcast is a part of CHEST's Bridging Specialties®: Timely Diagnosis and Treatment for COPD program. Access more resources at chestnet.org/timely-diagnosis-COPD.

Early recognition and diagnosis of nontuberculosis mycobacteria (NTM) and bronchiectasis are key for optimal patient management. However, these conditions are often misdiagnosed as COPD or asthma, leading to significant challenges and delays in treatment. Join Nathan Falk, MD, MBA, and Ashwin Basavaraj, MD, FCCP, as they share perspectives on accurately diagnosing NTM and bronchiectasis with early symptom recognition, a thorough patient history, and testing.

This episode is part of CHEST’s Bridging Specialties®: Timely Diagnosis for NTM Disease and Bronchiectasis program.

This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated.

In this episode, experts discuss the challenges of diagnosing and managing refractory chronic cough—a persistent cough that is often misunderstood and mismanaged. Drawing on findings from a recent CHEST/GSK survey, the conversation highlights gaps in patient evaluation, current treatment barriers, and opportunities to improve care through standardized protocols, better history-taking, and greater awareness of emerging therapies.

This podcast is a non-promotional, non-CME educational program brought to you by CHEST in collaboration with GSK.

A man in his late 60s enters a lung cancer screening program and is found to have a 4.5 cm tumor—stage II by size, with high-stakes decisions ahead. The case seems to point toward modern perioperative therapy, until biomarker testing changes everything. In this episode, host Lisa Moores, MD, FCCP, is joined by CHEST Guideline Chair John Howington, MD, MBA, FCCP, and oncologist Natasha Leighl, MD, to show how multidisciplinary care—and molecular results—can reroute the entire treatment journey.

They discuss why nodal staging matters, when perioperative therapy improves outcomes, and how biomarker-driven choices can reshape the safest path, while still leaving room for shared decision-making.

Faculty

• Host: Lisa Moores, MD, FCCP

• Guideline Chair: John Howington, MD, MBA, FCCP

• Case Guest: Natasha Leighl, MD